Branded Legacy, Inc. Acquires MariJPharmaceuticals to Bolster CBD Production and Intellectual Property

LOS ANGELES – In a notable expansion of its operations, Branded Legacy, Inc. announced on Tuesday the acquisition of Florida-based MariJ Pharmaceuticals, Inc., a company specializing in certified organic mobile extraction and production of CBD from industrial hemp. This strategic move, which was finalized on Monday, December 4, 2023, marks a significant milestone in Branded Legacy’s journey to consolidate its presence in the CBD industry.

What Happened The acquisition encompasses two distinct entities under the MariJ brand, each contributing unique strengths and licenses to Branded Legacy’s portfolio. The deal, detailed in a recent press release, includes the transfer of specialized operational assets, notably two customized trucks – an International and a Freightliner – designed to optimize operational flexibility and market reach.

Financially, the acquisition is structured as a combination of preferred series stock and cash. The terms include a buyback option and a lockout/leak agreement for the shares issued.

Why It Matters This acquisition significantly bolsters Branded Legacy’s asset base and intellectual property. It introduces a suite of valuable physical and intellectual assets into the company’s fold, including a compounding pharmacy license and a state-of-the-art supercritical CO2 extraction unit. The deal also brings an inventory of certified organic refined CBD, a fleet of licensed and permitted vehicles outfitted as complete extraction facilities, and a sophisticated refinement lab with food-safe production capabilities.

Additionally, the acquisition encompasses a range of operational tools such as advanced chillers, refrigerators, precision scales, an industrial biomass grinder, and a diverse selection of terpenes, flavorings, and essential lab supplies. A notable inclusion is a patent for extraction and processing, which enriches Branded Legacy’s IP portfolio.

The integration of MariJ’s operational framework into Branded Legacy is comprehensive, incorporating proven product formulations and a history of profitability. The acquisition also extends to digital and intellectual assets, including customer and operational databases, CRM systems, multiple domains, and websites. It solidifies Branded Legacy’s market position by adding permits, trademarks, and organic certifications.

Dave Oswald, CEO of Branded Legacy, emphasizes the strategic alignment of this acquisition with the company’s growth vision and market leadership aspirations. He highlights the acquisition’s role in enhancing product range, production capabilities, and the addition of valuable intellectual property and operational assets.

What’s Next With the integration of MariJ’s assets and capabilities, Branded Legacy is poised to enhance its product offerings and services, reaffirming its commitment to excellence in the health and wellness sector. Rick Pertile, CEO of MariJ Pharmaceuticals, expressed his enthusiasm for the deal, foreseeing significant value increase and advancements as part of Branded Legacy.

BLEG Price Action Following the announcement, Branded Legacy’s stock reflected positive market response, with shares trading 12.94% higher at $0.0035 per share after Monday’s market close. This upward trend underscores the market’s optimistic reception of the acquisition and its potential impact on Branded Legacy’s future growth and positioning in the competitive CBD market.